A PMHNP is treating a 50-year-old patient with recurrent MDD who has been stable on fluoxetine for 2 years. The patient states he wants to stop his medication because he feels better. He demonstrates full understanding of the risks of discontinuation, including his history of relapse. What should the PMHNP do?